{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T20:30:20Z","timestamp":1791232220383,"version":"4.1.0"},"reference-count":22,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2004,5,1]],"date-time":"2004-05-01T00:00:00Z","timestamp":1083369600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["International Journal of Antimicrobial Agents"],"published-print":{"date-parts":[[2004,5]]},"DOI":"10.1016\/j.ijantimicag.2003.10.003","type":"journal-article","created":{"date-parts":[[2004,4,28]],"date-time":"2004-04-28T08:31:00Z","timestamp":1083141060000},"page":"506-509","source":"Crossref","is-referenced-by-count":23,"title":["Resistance of uropathogens in symptomatic urinary tract infections in Le\u00f3n, Nicaragua"],"prefix":"10.1016","volume":"23","author":[{"given":"A.J","family":"Matute","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E","family":"Hak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.A.M","family":"Schurink","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A","family":"McArthur","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E","family":"Alonso","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M","family":"Paniagua","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E","family":"van Asbeck","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.M","family":"Roskott","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"F","family":"Froeling","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M","family":"Rozenberg-Arska","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"I.M","family":"Hoepelman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ijantimicag.2003.10.003_BIB1","doi-asserted-by":"crossref","first-page":"535","DOI":"10.3109\/00365548809032503","article-title":"Clinical and bacteriological affects of therapy of urinary tract infection in primary health care: relation to in vitro testing","volume":"20","author":"Ferry","year":"1988","journal-title":"Scand. J. Infect. Dis."},{"key":"10.1016\/j.ijantimicag.2003.10.003_BIB2","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1080\/02813430050202532","article-title":"Urinary tract infections, antibiotic resistance and sales of antimicrobial drugs","volume":"18","author":"Olafsson","year":"2000","journal-title":"Scand. J. Prim. Health Care"},{"key":"10.1016\/j.ijantimicag.2003.10.003_BIB3","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1179\/000349803125002850","article-title":"Prevalence and antimicrobial sensitivity pattern in urinary tract infection in febrile under- 5s at a children\u2019s emergency unit in Nigeria","volume":"23","author":"Musa-Aisien","year":"2003","journal-title":"Ann. Trop. Pediatr."},{"key":"10.1016\/j.ijantimicag.2003.10.003_BIB4","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1016\/S0950-3552(05)80325-6","article-title":"Urinary tract infections complicating pregnancy","volume":"8","author":"Cunninghan","year":"1994","journal-title":"Bailers Clin. Obstet. Gynaecol."},{"key":"10.1016\/j.ijantimicag.2003.10.003_BIB5","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1093\/oxfordjournals.aje.a117402","article-title":"Clinical infections in the non institutionalized geriatric age group: Methods utilized and incidence of infections","volume":"141","author":"Ruben","year":"1995","journal-title":"And. J. Epidemiol."},{"key":"10.1016\/j.ijantimicag.2003.10.003_BIB6","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1016\/S0924-8579(02)00090-0","article-title":"Pathogenesis of bacteriuria in women with diabetes mellitus","volume":"19","author":"Geerlings","year":"2002","journal-title":"Int. J. Antimicrob. Agents"},{"key":"10.1016\/j.ijantimicag.2003.10.003_BIB7","doi-asserted-by":"crossref","first-page":"1583","DOI":"10.1001\/jama.283.12.1583","article-title":"Comparison of ciprofloxacin (7 days) and trimethoprim\u2013sulfamethoxazole (14 days) for acute uncomplicated pyelonephritis in women","volume":"283","author":"Talan","year":"2000","journal-title":"JAMA"},{"key":"10.1016\/j.ijantimicag.2003.10.003_BIB8","doi-asserted-by":"crossref","first-page":"1165","DOI":"10.1086\/339812","article-title":"Empiric use of trimethoprim\u2013sulfamethoxazole (TMP\u2013SMX) in the treatment of women with uncomplicated urinary tract infections, in a geographical area with a high prevalence of TMP\u2013SMX-resistant uropathogens","volume":"34","author":"Raz","year":"2002","journal-title":"Clin. Infect. Dis."},{"issue":"suppl 1","key":"10.1016\/j.ijantimicag.2003.10.003_BIB9","doi-asserted-by":"crossref","first-page":"S216","DOI":"10.1093\/clind\/15.Supplement_1.S216","article-title":"General guidelines for the evaluation of new anti-infective drugs for the treatment of urinary tract infection","volume":"15","author":"Rubin","year":"1992","journal-title":"Clin. Infect. Dis."},{"key":"10.1016\/j.ijantimicag.2003.10.003_BIB10","unstructured":"Wood GL, Washington JA. Antimicrobial susceptibility test dilution and desk diffusion methods. In: Murray PR, Baron EJ, Pfaller MA, Tenover FC, Yolken RH, editors. Manual of Clinical Microbiology. 6th ed. Washington: American Society for Microbiology; 1995. p. 1327\u201341."},{"key":"10.1016\/j.ijantimicag.2003.10.003_BIB11","unstructured":"Nava L, Fiorentini, Stena MM. Comparative study of the microbiological components in urinary tract infections. J It Chemother 1989;36:69\u201387."},{"key":"10.1016\/j.ijantimicag.2003.10.003_BIB12","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/S0195-6701(98)90274-2","article-title":"Community acquired urinary tract infections in adults","volume":"38","author":"Finkelsteim","year":"1998","journal-title":"J. Hosp. Infect."},{"key":"10.1016\/j.ijantimicag.2003.10.003_BIB13","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/S0924-8579(02)00244-3","article-title":"Antimicrobial resistance in Escherichia coli causing urinary tract infection in Costa Rica: a clinical dilemma","volume":"21","author":"Williams","year":"2003","journal-title":"Int. J. Antimicrob. Agents"},{"key":"10.1016\/j.ijantimicag.2003.10.003_BIB14","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1086\/320880","article-title":"Antimicrobial resistance among uropathogens that cause community-acquired urinary tract infections in women: a national analysis","volume":"33","author":"Gupta","year":"2001","journal-title":"Clin. Infect. Dis."},{"key":"10.1016\/j.ijantimicag.2003.10.003_BIB15","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1016\/S0732-8893(02)00470-4","article-title":"Urinary tract infection trends in Latin American hospitals: report from the SENTRY antimicrobial surveillance program (1997\u20132000)","volume":"44","author":"Gales","year":"2002","journal-title":"Diagn. Microbiol. Infect. Dis."},{"key":"10.1016\/j.ijantimicag.2003.10.003_BIB16","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1053\/jinf.2002.1091","article-title":"A UK multicentre study of the antimicrobial susceptibility of bacterial pathogens causing urinary tract infection","volume":"46","author":"Forrell","year":"2003","journal-title":"J. Infect."},{"key":"10.1016\/j.ijantimicag.2003.10.003_BIB17","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/S0924-8579(02)00050-X","article-title":"Pathogen occurrence and antimicrobial resistance trends among urinary tract infection isolates in the Asia-Western Pacific Region: report from the SENTRY antimicrobial surveillance program, 1998\u20131999","volume":"20","author":"Turnidge","year":"2002","journal-title":"Int. J. Antimicrob. Agents"},{"key":"10.1016\/j.ijantimicag.2003.10.003_BIB18","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1093\/jac\/45.3.295","article-title":"Activity and spectrum of 22 antimicrobial agents tested against urinary tract infection pathogens in hospitalized patients in Latin America: report from the second year of the SENTRY antimicrobial surveillance program","volume":"45","author":"Gales","year":"2000","journal-title":"J. Antimicrob. Chemother."},{"key":"10.1016\/j.ijantimicag.2003.10.003_BIB19","doi-asserted-by":"crossref","first-page":"7","DOI":"10.2165\/00044011-200121001-00002","article-title":"Resistance among urinary pathogens: experience outside the USA","volume":"21","author":"Felmingham","year":"2001","journal-title":"Clin. Drug Invest."},{"issue":"1","key":"10.1016\/j.ijantimicag.2003.10.003_BIB20","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/S0891-5520(05)70218-X","article-title":"Bacterial resistance to antimicrobial agents in Latin America: the giant is awakening","volume":"14","author":"Guzman","year":"2000","journal-title":"Infect. Dis. Clin. North Am."},{"key":"10.1016\/j.ijantimicag.2003.10.003_BIB21","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1086\/520427","article-title":"Guidelines for antimicrobial treatment of uncomplicated acute bacterial cystitis and acute pyelonephritis in women","volume":"29","author":"Warren","year":"1999","journal-title":"Clin. Infect. Dis."},{"key":"10.1016\/j.ijantimicag.2003.10.003_BIB22","unstructured":"National Committee for Clinical Laboratory Standards. Performance standards for antimicrobial susceptibility testing. Supplemental M100\u2013S11. Wayne, PA: National Committee for Clinical Laboratory Standards; 2001."}],"container-title":["International Journal of Antimicrobial Agents"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0924857904000445?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0924857904000445?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,2,10]],"date-time":"2019-02-10T01:54:50Z","timestamp":1549763690000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0924857904000445"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2004,5]]},"references-count":22,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2004,5]]}},"alternative-id":["S0924857904000445"],"URL":"https:\/\/doi.org\/10.1016\/j.ijantimicag.2003.10.003","relation":{},"ISSN":["0924-8579"],"issn-type":[{"value":"0924-8579","type":"print"}],"subject":[],"published":{"date-parts":[[2004,5]]}}}